Diagu.com is an internationally operating startup founded in 2020 and based in Poland. The company is part of the Microsoft for Start-ups program and specializes in AI diagnostic solutions for healthcare. With a recent $2.00M Seed Round investment from FasterCapital in July 18, 2021, Diagu aims to empower the healthcare sector by providing a platform that utilizes artificial intelligence to analyze laboratory test results and patient data, enabling accurate and efficient disease diagnosis.
The Diagu system assesses patients' laboratory test results, medical history, previous diagnoses, and medications, using advanced AI solutions from Microsoft and Amazon Partner programs. The platform ensures data security through integration with HL7 and FHIR standards and complies with disease description standards developed in cooperation with WHO and SNOMED.
Collaborating with world-class specialists and industry partners, Diagu is positioned as a versatile tool applicable in primary and hospital care, insurance, and the analytical assessment of large data sets. The recent investment not only reflects investor confidence in the startup but also supports the ongoing development and wide-scale application of its innovative solutions.